Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 770,125 |
|
|||||
| News | - | ||||||
| Day High | 4.555 | Low High |
|||||
| Day Low | 4.165 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Applied Therapeutics Inc | APLT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.15 | -3.36% | 4.31 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.50 | 4.165 | 4.555 | 4.31 | 4.46 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,668 | 770,125 | $ 4.30 | $ 3,310,753 | - | 1.03 - 9.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:47:33 | 1 | $ 4.43 | USD |
Applied Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 455.31M | 105.89M | - | 9.99M | -119.76M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Applied Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APLT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.10 | 5.23 | 4.165 | 4.50 | 1,198,037 | -0.79 | -15.49% |
| 1 Month | 6.70 | 7.166 | 4.165 | 5.49 | 1,006,952 | -2.39 | -35.67% |
| 3 Months | 2.95 | 9.39 | 2.585 | 5.58 | 1,911,593 | 1.36 | 46.10% |
| 6 Months | 2.49 | 9.39 | 1.79 | 4.30 | 1,585,650 | 1.82 | 73.09% |
| 1 Year | 1.16 | 9.39 | 1.03 | 3.59 | 1,131,692 | 3.15 | 271.55% |
| 3 Years | 16.59 | 25.59 | 0.4995 | 3.59 | 542,612 | -12.28 | -74.02% |
| 5 Years | 8.04 | 57.39 | 0.4995 | 7.41 | 382,235 | -3.73 | -46.39% |
Applied Therapeutics Description
| Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart. |
